Search Results 3301-3310 of 18731 for SAD
Sara Carlson is a certified diabetes educator in the Department of Endocrinology at Mayo Clinic, Rochester, Minnesota. Sara graduated from Winona State ...
The purpose of this study is to evaluate the safety, tolerability, and preliminary anti-tumor activity of SAR444881 alone and in combination with pembrolizumab ...
"When I came to Saint Marys, it was like coming home," Big Jim says. Share · Tweet . IMG-20094016. Home; ddp-james-crossingham-6col ...
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor ...
2025. Mayo Clinic Minute: Know the warning signs of hypertrophic cardiomyopathy Feb. 21, 2025, 03:50 p.m. CDT. 2024. Mayo Clinic Q & A: What is hypertrophic ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
Join the fight against cancer! ... Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated. Give Now.
Damage to brain cells in two separate neurodegenerative diseases — Alzheimer's disease and progressive supranuclear palsy — is not limited to specific parts ...
ICU nurses are at high risk of developing PTSD due to regular and ongoing exposure to death and tragedy. This study will lead to improvements in understanding ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.